Physicians Welcome Testosterone Labeling Changes

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be removed, the FDA announced.
Medscape Medical News